Asthma (Respiratory) – Drugs In Development, 2021

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Drugs In Development, 2021, provides an overview of the Asthma (Respiratory) pipeline landscape.Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Asthma – Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Asthma (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 1, 16, 40, 48, 10, 136, 38 and 9 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 33 and 10 molecules, respectively.

Asthma (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Asthma (Respiratory).

– The pipeline guide reviews pipeline therapeutics for Asthma (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Asthma (Respiratory) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Asthma (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Asthma (Respiratory)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Asthma (Respiratory).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Asthma (Respiratory) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies mentioned

2A Pharma AB

3SBio Inc

4D Pharma Plc

AazeinTx Inc

AB Science SA

AbbVie Inc

Abeome Corp

Actinobac Biomed Inc

Adare Pharma Solutions

Advagene Biopharma Co Ltd

Aeon Respire Inc

Airbase Breathing Co LLC

Akeso Inc

Aldeyra Therapeutics Inc

Algomedix Inc

ALK-Abello AS

AllerGen NCE Inc

Allergy Therapeutics Plc

Amgen Inc

Amphastar Pharmaceuticals Inc

AnGes Inc

Antisense Therapeutics Ltd

Apollo Therapeutics LLC

Daewoong Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Defensin Therapeutics ApS

Dnarx LLC

EffectorBio Inc

EmphyCorp Inc

IGE Therapeutics Inc

ILiAD Biotechnologies LLC

ImmuNext Inc

Inatherys

Incannex Healthcare Ltd

InKemia IUCT Group SA

InnoPharmaScreen Inc

Innovimmune Biotherapeutics Inc

Inspyr Therapeutics Inc

InStatin Inc

Invion Ltd

Io Therapeutics Inc

Ionis Pharmaceuticals Inc

Irex Pharma LLC

Jiangsu Hengrui Medicine Co Ltd

JiangSu Qyuns Therapeutics Co Ltd

Joincare Pharmaceutical Group Industry Co Ltd

JW Pharmaceutical Corp

Kashiv BioSciences LLC

KBP Biosciences Holdings Ltd

KeyMed Biosciences Inc

Kinaset Therapeutics Inc

Kissei Pharmaceutical Co Ltd

Kither Biotech Srl

Knopp Biosciences LLC

KoBioLabs Inc

Korea United Pharm Inc

Kyowa Kirin Co Ltd

Landos Biopharma Inc

Laurel Therapeutics

Lead Discovery Center GmbH

Lignamed LLC

Liminal BioSciences Inc

Longevity Biotech Inc

Mabpharm Ltd

Mabtech Ltd

Mabwell Shanghai Bioscience Co Ltd

Mariposa Health Ltd

MD Healthcare Inc

Medicenna Therapeutics Corp

Mercia Pharma Inc

Merck & Co Inc

MitoImmune Therapeutics Inc

Mitsubishi Tanabe Pharma Corp

Mycenax Biotech Inc

NAL Pharmaceuticals Ltd

NeoPharm Co Ltd

Neovacs SA

NeuImmune Inc

Nexeos Bio

NovaCell Technology Inc

NovaRock Biotherapeutics Inc

Novartis AG

Omeros Corp

OncoArendi Therapeutics SA

Oneness Biotech Co Ltd

Opsidio LLC

Orchid Pharma Ltd

Orphomed Inc

Oxagen Ltd

Palo BioFarma SL

Pantherics Inc

Paradigm Biopharmaceuticals Ltd

Paragen Bio Pty Ltd

Pfizer Inc

PharmAbcine Inc

PharmaKing Co Ltd

Pharmaxis Ltd

Pieris Pharmaceuticals Inc

Principia Biopharma Inc

Progenra Inc

Prommune Inc

Prous Institute for Biomedical Research SA

PSK Pharma Pvt Ltd

Pulmatrix Inc

Pulmokine Inc

Qu Biologics Inc

Quench Medical Inc

Qurient Co Ltd

RAFT Pharmaceuticals

RAGE Biotech Pty Ltd

RAPT Therapeutics Inc

Re-Pharm Ltd

Regeneron Pharmaceuticals Inc

Respiratorius AB

Revalesio Corp

Revolo Biotherapeutics Ltd

Ribomic Inc

S-TARget therapeutics GmbH

Sama Pharm Co Ltd

Sanofi

Santhera Pharmaceuticals Holding AG

Seelos Therapeutics, Inc.

Shandong Boan Biotechnology Co Ltd

Shanghai KE Pharmaceutical Co Ltd

Shanghai Kexin Biotech Co Ltd

Shanghai Maiji Biotechnology Co Ltd

Shanghai Novamab Biopharmaceuticals Co Ltd

Shenzhen Forward Pharmaceutical Co Ltd

Shouyao Holding Co Ltd

Sichuan Yuanda Shuyang Pharmaceutical Co Ltd

Siolta Therapeutics Inc

SolAeroMed Inc

sterna biologicals Gmbh & Co KG

Suzhou Connect Biopharmaceuticals Ltd

Synermore Biologics Co Ltd

Taiho Pharmaceutical Co Ltd

TaiwanJ Pharmaceuticals Co Ltd

TAK-Circulator Corp

Tarus Therapeutics Inc

TCF GmbH

Tetherex Pharmaceuticals Corp

Tetragenetics Inc

Teva Pharmaceutical Industries Ltd

TFF Pharmaceuticals Inc

The Geneva Biotech Center SA

The United Laboratories International Holdings Ltd

Torrent Pharmaceuticals Ltd

Translational Biosciences

Trio Medicines Ltd

Tunitas Therapeutics Inc

United Biomedical Inc

Vactech Oy

Vanworld Pharmaceutical (Rugao) Company Ltd

Vascular BioSciences

Vasomune Inc

Vectura Group Plc

Verona Pharma Plc

VGSK Technologies Inc

Vicenna Pharmaceuticals Inc

Virtici LLC

Yuhan Corp

Zhejiang Hisun Pharmaceutical Co Ltd

Zhengda Tianqing Pharmaceutical Group Co Ltd

Zhuhai Trinomab Biotechnology Co Ltd

Table of Contents

Table of Contents

Introduction

Asthma - Overview

Asthma - Therapeutics Development

Asthma - Therapeutics Assessment

Asthma - Companies Involved in Therapeutics Development

Asthma - Drug Profiles

Asthma - Dormant Projects

Asthma - Discontinued Products

Asthma - Product Development Milestonesh

Appendix

List of Tables

List of Tables

Number of Products under Development for Asthma, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Asthma – Pipeline by 2A Pharma AB, 2021

Asthma – Pipeline by 3SBio Inc, 2021

Asthma – Pipeline by 4D Pharma Plc, 2021

Asthma – Pipeline by AazeinTx Inc, 2021

Asthma – Pipeline by AB Science SA, 2021

Asthma – Pipeline by AbbVie Inc, 2021

Asthma – Pipeline by Abeome Corp, 2021

Asthma – Pipeline by Actinobac Biomed Inc, 2021

Asthma – Pipeline by Adare Pharma Solutions, 2021

Asthma – Pipeline by Advagene Biopharma Co Ltd, 2021

Asthma – Pipeline by Aeon Respire Inc, 2021

Asthma – Pipeline by Airbase Breathing Co LLC, 2021

Asthma – Pipeline by Akeso Inc, 2021

Asthma – Pipeline by Aldeyra Therapeutics Inc, 2021

Asthma – Pipeline by Algomedix Inc, 2021

Asthma – Pipeline by ALK-Abello AS, 2021

Asthma – Pipeline by AllerGen NCE Inc, 2021

Asthma – Pipeline by Allergy Therapeutics Plc, 2021

Asthma – Pipeline by Amgen Inc, 2021

Asthma – Pipeline by Amphastar Pharmaceuticals Inc, 2021

Asthma – Pipeline by AnGes Inc, 2021

Asthma – Pipeline by Antisense Therapeutics Ltd, 2021

Asthma – Pipeline by Apollo Therapeutics LLC, 2021

Asthma – Pipeline by Aquilon Pharmaceuticals SA, 2021

Asthma – Pipeline by Argenx SE, 2021

Asthma – Pipeline by Artax Biopharma Inc, 2021

Asthma – Pipeline by Artizan Biosciences Inc, 2021

Asthma – Pipeline by ASIT Biotech SA, 2021

Asthma – Pipeline by Aslan Pharmaceuticals Ltd, 2021

Asthma – Pipeline by AstraZeneca Plc, 2021

Asthma – Pipeline by Athos Therapeutics Inc, 2021

Asthma – Pipeline by Atrapos Therapeutics LLC, 2021

Asthma – Pipeline by AusBio Ltd, 2021

Asthma – Pipeline by Avidin Biotechnology Ltd, 2021

Asthma – Pipeline by Bai Shuo Beijing Pharmaceutical Technology Co Ltd, 2021

Asthma – Pipeline by Bilix Co Ltd, 2021

Asthma – Pipeline by BioArdis LLC, 2021

Asthma – Pipeline by Biocon Ltd, 2021

Asthma – Pipeline by Biohaven Pharmaceutical Holding Company Ltd, 2021

Asthma – Pipeline by BiOraliX BV, 2021

Asthma – Pipeline by BiosanaPharma BV, 2021

Asthma – Pipeline by Biosion Inc, 2021

Asthma – Pipeline by Biotoxtech Co Ltd, 2021

Asthma – Pipeline by Boehringer Ingelheim International GmbH, 2021

Asthma – Pipeline by Celltrion Inc, 2021

Asthma – Pipeline by Celon Pharma SA, 2021

Asthma – Pipeline by Centrymed Pharmaceutical Inc, 2021

Asthma – Pipeline by Chia Tai Tianqing Pharmaceutical Group Co Ltd, 2021

Asthma – Pipeline by Chiesi Farmaceutici SpA, 2021

Asthma – Pipeline by Chronic Airway Therapeutics Ltd, 2021

Asthma – Pipeline by Crossject SA, 2021

Asthma – Pipeline by CrystalGenomics Inc, 2021

Asthma – Pipeline by CSL Ltd, 2021

Asthma – Pipeline by CSPC Pharmaceutical Group Ltd, 2021

Asthma – Pipeline by Cumberland Pharmaceuticals Inc, 2021

Asthma – Pipeline by Curovir AB, 2021

Asthma – Pipeline by Cynata Therapeutics Ltd, 2021

Asthma – Pipeline by Cytokinetics Inc, 2021

Asthma – Pipeline by Daewoong Pharmaceutical Co Ltd, 2021

Asthma – Pipeline by Daiichi Sankyo Co Ltd, 2021

Asthma – Pipeline by Defensin Therapeutics ApS, 2021

Asthma – Pipeline by Dnarx LLC, 2021

Asthma – Pipeline by EffectorBio Inc, 2021

Asthma – Pipeline by EmphyCorp Inc, 2021

Asthma – Pipeline by Energenesis Biomedical Co Ltd, 2021

Asthma – Pipeline by Enzychem Lifesciences Corp, 2021

Asthma – Pipeline by Epsilon Molecular Engineering Inc, 2021

Asthma – Pipeline by ethris GmbH, 2021

Asthma – Pipeline by EURRUS Biotech GmbH, 2021

Asthma – Pipeline by Evelo Biosciences Inc, 2021

Asthma – Pipeline by Evergreen Therapeutics Inc, 2021

Asthma – Pipeline by Exotect LLC, 2021

Asthma – Pipeline by Fibrotherapeutics Inc, 2021

Asthma – Pipeline by Foresee Pharmaceuticals Co Ltd, 2021

Asthma – Pipeline by Galapagos NV, 2021

Asthma – Pipeline by Genentech USA Inc, 2021

Asthma – Pipeline by Generium, 2021

Asthma – Pipeline by GeneScience Pharmaceuticals Co Ltd, 2021

Asthma – Pipeline by Genrix (Shanghai) Biopharmaceutical Co Ltd, 2021

Asthma – Pipeline by GI Innovation Co Ltd, 2021

Asthma – Pipeline by GlaxoSmithKline Plc, 2021

Asthma – Pipeline by Glenmark Pharmaceuticals Ltd, 2021

Asthma – Pipeline by GliaCure Inc, 2021

Asthma – Pipeline by GlycoMira Therapeutics Inc, 2021

Asthma – Pipeline by Gossamer Bio Inc, 2021

Asthma – Pipeline by Gurus BioPharm, 2021

Asthma – Pipeline by Harbour BioMed (Guangzhou) Co Ltd, 2021

Asthma – Pipeline by HEC Pharma Co Ltd, 2021

Asthma – Pipeline by Re-Pharm Ltd, 2021

Asthma – Pipeline by Regeneron Pharmaceuticals Inc, 2021

Asthma – Pipeline by Respiratorius AB, 2021

Asthma – Pipeline by Revalesio Corp, 2021

Asthma – Pipeline by Revolo Biotherapeutics Ltd, 2021

Asthma – Pipeline by Ribomic Inc, 2021

Asthma – Pipeline by S-TARget therapeutics GmbH, 2021

Asthma – Pipeline by Sama Pharm Co Ltd, 2021

Asthma – Pipeline by Sanofi, 2021

Asthma – Pipeline by Santhera Pharmaceuticals Holding AG, 2021

Asthma – Pipeline by Seelos Therapeutics, Inc., 2021

Asthma – Pipeline by Shandong Boan Biotechnology Co Ltd, 2021

Asthma – Pipeline by Shanghai KE Pharmaceutical Co Ltd, 2021

Asthma – Pipeline by Shanghai Kexin Biotech Co Ltd, 2021

Asthma – Pipeline by Shanghai Maiji Biotechnology Co Ltd, 2021

Asthma – Pipeline by Shanghai Novamab Biopharmaceuticals Co Ltd, 2021

Asthma – Pipeline by Shenzhen Forward Pharmaceutical Co Ltd, 2021

Asthma – Pipeline by Shouyao Holding Co Ltd, 2021

Asthma – Pipeline by Sichuan Yuanda Shuyang Pharmaceutical Co Ltd, 2021

Asthma – Pipeline by Siolta Therapeutics Inc, 2021

Asthma – Pipeline by SolAeroMed Inc, 2021

Asthma – Pipeline by sterna biologicals Gmbh & Co KG, 2021

Asthma – Pipeline by Suzhou Connect Biopharmaceuticals Ltd, 2021

Asthma – Pipeline by Synermore Biologics Co Ltd, 2021

Asthma – Pipeline by Taiho Pharmaceutical Co Ltd, 2021

Asthma – Pipeline by TaiwanJ Pharmaceuticals Co Ltd, 2021

Asthma – Pipeline by TAK-Circulator Corp, 2021

Asthma – Pipeline by Tarus Therapeutics Inc, 2021

Asthma – Pipeline by TCF GmbH, 2021

Asthma – Pipeline by Tetherex Pharmaceuticals Corp, 2021

Asthma – Pipeline by Tetragenetics Inc, 2021

Asthma – Pipeline by Teva Pharmaceutical Industries Ltd, 2021

Asthma – Pipeline by TFF Pharmaceuticals Inc, 2021

Asthma – Pipeline by The Geneva Biotech Center SA, 2021

Asthma – Pipeline by The United Laboratories International Holdings Ltd, 2021

Asthma – Pipeline by Torrent Pharmaceuticals Ltd, 2021

Asthma – Pipeline by Translational Biosciences, 2021

Asthma – Pipeline by Trio Medicines Ltd, 2021

Asthma – Pipeline by Tunitas Therapeutics Inc, 2021

Asthma – Pipeline by United Biomedical Inc, 2021

Asthma – Pipeline by Vactech Oy, 2021

Asthma – Pipeline by Vanworld Pharmaceutical (Rugao) Company Ltd, 2021

Asthma – Pipeline by Vascular BioSciences, 2021

Asthma – Pipeline by Vasomune Inc, 2021

Asthma – Pipeline by Vectura Group Plc, 2021

Asthma – Pipeline by Verona Pharma Plc, 2021

Asthma – Pipeline by VGSK Technologies Inc, 2021

Asthma – Pipeline by Vicenna Pharmaceuticals Inc, 2021

Asthma – Pipeline by Virtici LLC, 2021

Asthma – Pipeline by Yuhan Corp, 2021

Asthma – Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, 2021

Asthma – Pipeline by Zhengda Tianqing Pharmaceutical Group Co Ltd, 2021

Asthma – Pipeline by Zhuhai Trinomab Biotechnology Co Ltd, 2021

Asthma – Dormant Projects, 2021

Asthma – Discontinued Products, 2021

List of Figures

List of Figures

Number of Products under Development for Asthma, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Top 10 Targets, 2021

Number of Products by Stage and Top 10 Targets, 2021

Number of Products by Top 10 Mechanism of Actions, 2021

Number of Products by Stage and Top 10 Mechanism of Actions, 2021

Number of Products by Top 10 Routes of Administration, 2021

Number of Products by Stage and Top 10 Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports